[The antiphospholipid antibody syndrome: a new clinical and therapeutic viewpoint in systemic lupus erythematosus].
Bravo-Vargas
G
G
Lavalle-Montalvo
C
C
D001323:Autoantibodies / Q000032:analysis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology*; D001779:Blood Coagulation Factors / Q000276:immunology*; D002308:Cardiolipins / Q000276:immunology; D005189:False Positive Reactions; D006801:Humans; D016682:Lupus Coagulation Inhibitor; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000276:immunology*; D010743:Phospholipids / Q000276:immunology*; D013577:Syndrome; D013923:Thromboembolism / Q000209:etiology
D001323:Autoantibodies; D001779:Blood Coagulation Factors; D002308:Cardiolipins; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids
El síndrome de anticuerpos antifosfolípidos: un nuevo enfoque clínico y terapéutico en el lupus eritematoso sistémico.